Peer support in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): a qualitative study
Hermioni L. Amonoo(Brigham and Women's Hospital), Areej El‐Jawahri(Massachusetts General Hospital), Jeff C. Huffman(Harvard University), Stephanie J. Lee(Fred Hutch Cancer Center), Lauren E. Harnedy(Massachusetts General Hospital), William F. Pirl(Johns Hopkins University), Lauren Goldschen(Brigham and Women's Hospital), Amar H. Kelkar(Harvard University), Anna Revette(Dana-Farber Cancer Institute), Emily H. Feig(Harvard University), Rachael Rosales(Brigham and Women's Hospital), Lara Traeger(Massachusetts General Hospital), Emma C. Deary(Brigham and Women's Hospital), Lydia Brown(The University of Melbourne), Elizabeth Daskalakis(Brigham and Women's Hospital), Corey Cutler(Dana-Farber Cancer Institute)
Cited by 27
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k
Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial
|Journal of Clinical Oncology|2017|834
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|458